PPARA and central nervous system cancer: Further immunohistochemical staining showed that after reducing the HOTAIR expression of gliomas, the expression of PPARΑ protein was increased, and the CD34 and Ki67 protein expression of the combined treatment group was lower than that of the other two groups.